Spots Global Cancer Trial Database for eln adverse genetic risk group
Every month we try and update this database with for eln adverse genetic risk group cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Phase I Study of UCART123 in Patient With Adverse Genetic Risk Acute Myeloid Leukemia | NCT04106076 | Acute Myeloid L... | UCART123 | 18 Years - 65 Years | Cellectis S.A. |